Tuesday, November 18, 2014

Hazardous Drugs bicalutimide to daunorubicin


bicalutimide 10:00 antineoplastic agents FDA Pregnancy Category X DailyMed; DrugBank
bleomycin 10:00 antineoplastic agents
yes
IARC Group 2B; FDA Pregnancy Category D DailyMed; DrugBank
bortezomib 10:00 antineoplastic agents
yes
FDA Pregnancy Category D DailyMed; DrugBank
brentuximab vedotin 10:00 antineoplastic agents
yes
Conjugated monoclonal antibody; FDA Pregnancy Category D DailyMed; DrugBank
busulfan 10:00 antineoplastic agents
yes
IARC Group 1 carcinogen; FDA Pregnancy Category D DailyMed; DrugBank
cabazitaxel 10:00 antineoplastic agents
yes
FDA Pregnancy Category D DailyMed; DrugBank
capecitabine 10:00 antineoplastic agents
yes
Metabolized to 5-fluorouracil; FDA Pregnancy Category D DailyMed; DrugBank
carboplatin 10:00 antineoplastic agents
yes
FDA Pregnancy Category D DailyMed; DrugBank
carmustine 10:00 antineoplastic agents
yes
IARC Group 2A carcinogen; FDA Pregnancy Category D DailyMed; DrugBank
chlorambucil 10:00 antineoplastic agents
yes
IARC Group 1 carcinogen; FDA Pregnancy Category D DailyMed; DrugBank
cisplatin 10:00 antineoplastic agents
yes
IARC Group 2A carcinogen; FDA Pregnancy Category D DailyMed; DrugBank
cladribine 10:00 antineoplastic agents
yes
FDA Pregnancy Category D DailyMed; DrugBank
clofarabine 10:00 antineoplastic agents
yes
FDA Pregnancy Category D DailyMed; DrugBank
crizotinib 10:00 antineoplastic agents FDA Pregnancy Category D DailyMed
cyclophosphamide 10:00 antineoplastic agents
yes
IARC Group 1 carcinogen; FDA Pregnancy Category D DailyMed; Drugbank
cytarabine 10:00 antineoplastic agents
yes
FDA Pregnancy Category D DailyMed; DrugBank
dacarbazine 10:00 antineoplastic agents
yes
FDA Pregnancy Category C DailyMed; Drugbank
dactinomycin 10:00 antineoplastic agents
yes
FDA Pregnancy Category D DailyMed; DrugBank
dasatinib 10:00 antineoplastic agents
yes
FDA Pregnancy Category D DailyMed; Drugbank
daunorubicin 10:00 antineoplastic agents
yes
IARC Group 2B, AKA daunomycin; FDA Pregnancy Category D

DailyMed; Drugbank

No comments:

Post a Comment